Web
		Analytics
Life Sciences - Tego
Tego Logo
MENU

Tego Inc and TSC Printronix Auto ID Partner to Offer Complete Edge to Cloud Solution

The Partnership Serves Digital Transformation Initiatives in the Aviation, Automotive, Rail, and Healthcare Industries

 

WALTHAM MA SEPTEMBER 23, 2020 – Tego Inc announces partnership with TSC Printronix Auto ID, a global leader in the AIDC barcode printer industry. With this partnership, Tego’s Asset Intelligence Platform (AIP) is validated and proven for use across Printronix Auto ID RFID enabled printers. Together, the companies will serve manufacturers across several key industrial market sectors, including aerospace, automotive, life science, energy and healthcare.

Tego is the leading provider for commercial aerospace supply chain visibility solutions and co-author of the ATA Spec 2000 Ch.9-5 standard. As an automated identification aerospace authority, Tego’s validation of Printronix Auto ID RFID enabled printers means they are capable to encode and print UHF high-memory integrated labels to meet compliance with the ATA’s aerospace initiatives. Printronix Auto ID announces immediate availability of printers for sale to aerospace manufacturers, airlines and maintenance, repair and overhaul (MRO) organizations.

The Printronix Auto ID T800, T4000, and T6000e series provide a full portfolio of desktop and industrial four-inch and six-inch RFID enabled printers supporting both standard and on-metal RFID labels and tags. Designed for different print volumes, form-factors, and environmental conditions, all models support automatic RFID label calibration and the high-memory encoding functionalities to work with Tego’s software.

This partnership also offers industrial customers in automotive, rail and healthcare a complete end-to-end software solution via Tego’s award winning platform for asset tracking, supply chain visibility, and real-time location and traceability edge analytics. Tego’s platform solution integrates with enterprise software applications (e.g., SAP) and is configurable and scaleable supporting all major mobile and desktop operating systems including iOS, Android, Windows, and OS X. Lastly, since Tego has the only UHF RFID chip technology that is both gamma and e-beam sterilization proof, this partnership brings an end-to-end offering for both med tech and clean-room pharmaceutical manufacturing companies.

“Tego, together with Printronix Auto ID, provides a complete digital solution to track and trace industrial assets in both manufacturing and logistics supply chain” said Timothy Butler, CEO of Tego, Inc.

“In forging this strategic alliance we’ve enhanced our entire RFID printer portfolio to encode Tego’s high-memory RFID tags. This not only enables us to support Tego with their ATA 2000 commercial aerospace projects, but also gives us access to other markets that demand high-memory tags, such as automotive and healthcare,” said Sam Wang, President and CEO of TSC Printronix Auto ID.

 

About Tego Inc

Tego provides a complete asset tracking, supply chain and lifecycle management solution, providing edge intelligence in both disconnected and inhospitable environmental conditions. With thirty granted patents, Tego’s platform is an interoperable system for building rugged IoT solutions.

Tego, founded in 2005, is based in Waltham, MA. SAP, IOS, Android, ATA Spec 2000 are trademarks of their respective owners. Follow Tego on LinkedIn, Twitter and YouTube.

For more information, visit www.tegoinc.com

About TSC Printronix Auto ID

TSC Printronix Auto ID is a leading designer and manufacturer of innovative thermal printing solutions. The company is comprised of two-industry-leading brands, TSC and Printronix Auto ID with over 65 years of combined industry experience, strong local sales engineering support, continuous investment in new product development and is capable of quickly adapting solutions to meet the needs of small business customers to Fortune 500 companies. TSC and Printronix Auto ID are proud members of the TSC Auto ID Technology Company family. To learn more, visit TSC Auto ID at www.tscprinters.com and Printronix Auto ID at www.printronixautoid.com

Media contact:

LaVerne Cerfolio


Aseptic Tracking and Foolproof Quality Control

Digitized and Automated Chain of Custody and

Audit Information at Your Fingertips – Anywhere

For pharmaceutical manufacturers, product safety is non-negotiable. Violations could mean front-page news, lawsuits, or worse. Current aseptic environmental monitoring quality assurance practices rely heavily on labor-intensive paper-based methods, with only 15 percent of the market utilizing more automated methods like bar codes. Digital solutions can improve manufacturing effectiveness and facilitate reporting for environmental monitoring.

Learn how Tego helps to:

  • Automate data collection from devices and people.
  • Eliminate redundant data entry and transcription errors.
  • Improve worker efficiency.
  • Improve regulatory compliance.
  • Enable sound product and quality release decisions.

Sterilization Supply Chain

Rugged Tracking for Harsh Conditions:

Sterilization-Proof Supply Chain Tracking

The sterilization processes undertaken in life science supply chains, healthcare companies, biopharmaceutical manufacturers, nuclear laboratories and sterile processing industries are too harsh for typical RFID chips and tags. Tego’s sterilization-proof asset tracking solution is the only ultra-high-frequency solution to stand up to the brutality of gamma and e-beam sterilization.

Learn how Tego helps to:

  • Allow information to flow freely from the point of manufacture through a product’s entire lifecycle.
  • Uncover usage patterns, link outcomes to products and practices, identify waste, and reallocate and reduced working capital.

Can gamma-proof data stem the tide of aseptic manufacturing deficiencies?

In news that’s starting to sound like a broken vinyl record, instances of voluntary recall and FDA warnings continue to plague the aseptic manufacturing industry. To wit:

Baxter issued a voluntary recall for more than 427,000 units of sodium chloride injection and 54,528 containers of dextrose injection, citing “a lack of assurance of sterility” as the driving mechanism. (Read more on FiercePharma).

The FDA cited Tubilux for “deficiencies that include improper equipment use, insufficient laboratory controls, and problems with the company’s sterility assurance program.” (Read more on PharmTech.com).

And most recently, Rugby Laboratories just issued a major voluntarily recall for Diocto Liquid and Diocto Syrup. (Read more on Pharmaceutical Processing).

Even as the global market for environmental monitoring is estimated to reach $19.56 Billion by 2021, factors such as high costs of current proposed solutions, complicated implementation procedures, and high export barriers across emerging countries are restraining market growth.

How can gamma-survivable digital intelligence help? In an aseptic manufacturing environment, it transforms the very assets already in place into smart aids that keep better track of moment-by-moment conditions and process controls, to produce a more complete and verifiable record of sterility assurance.

The assets we’re talking about are those that monitor airborne particulates, active viable air, passive viable air and equipment surfaces, and facility personnel themselves. Whenever a drug or biologic goes through a given process or stage of production, these components gather digital records and time-stamped details about the manufacturing procedure, location or condition of the environment, which of course includes chain-of custody and information needed for regulatory compliance. These assets become embedded with a literal digital thread, to help downstream operators collect, manage, and report every stage of production including initial sterilization. The data then feeds the manufacturing clinical laboratory database and, quite simply, personnel are put in position to perform their jobs better. Operators, laboratory technicians, managers — even executives — can digitally access and sync component data, and call up production or sterility details about any individual unit at any time, even after a batch has been released to the market.

To learn about Tego’s gamma-proof intelligent solutions for pharmaceutical manufacturing, please visit this page.

To schedule a demo and see how Tego can improve your aseptic manufacturing processes, contact us here.


Tego Named a 2017 “All-Star Innovator” by Pharma Manufacturing

We are thrilled to report that Tego’s touchless, digital environmental monitoring solution for cGMP manufacturers was named an “All-Star” Innovation for 2017 by the editors of Pharmaceutical Manufacturing magazine. The program recognizes standout companies who produced technological innovation in pharma over the course of the prior year.

PM calls out Tego’s exemplary use of IIoT technology to enable precise tracking and verification of contaminant exposure on product, material or equipment across the production steps for aseptic pharmaceuticals. The promise of automated and touchless detection reduces the possibility of contamination, limits the potential for costly wasted batches, and allows for much more selective, granular recall procedures. All types of environmental monitoring – for airborne particulates, active viable air, passive viable air, surfaces, water and personnel – benefit from this sterilization-proof, digital solution.

Read the full article here.

To learn about Tego’s RFID chip and platform solutions for aseptic pharmaceutical manufacturers, visit this page.

To schedule a demo for how Tego can improve your aseptic operation, contact us here.


“Lack of sterility assurance” in CGMP strikes again: Hospira issues a recall

We learned late last week that Pfizer subsidiary Hospira issued a nationwide recall of its vials used to inject sodium bicarbonate, citing sterility concerns. Not only will this cause undue financial damage to the company, but more critically it removes a volume of potentially lifesaving drug from the market.

There’s a downstream impact, as well. PharMEDium Services had to recall a full run of its products that had been compounded using the affected Hospira lots. One sterility monitoring mix-up upstream creates a domino effect across the entire value chain.

Again, the difficulty manufacturers have with proving sterility across the entirety of their processes creates an outsized burden, not only for the manufacturer itself, but also for its partners and the healthcare community at-large. Unfortunately, the Hospira recall is but a time-stamped snapshot into how bioburden incidents add up annually, outlined in early Q2 2017 by Bioprocess Online.

Most importantly, this instance is a harsh reminder that a solvable issue continues to present a significant challenge. The good news is, there are new ways to overcome it. By storing digital data directly on a facility’s manufacturing components, monitoring processes can become automated and touchless, and manufacturers are more able to account for the possibility of contamination before lots are released to the market. This goes to mitigate against the potential for costly, brand damaging situations to occur. There’s much less chance for sterility to be compromised because operator touches have been reduced and digital information has been made readily available for easy access. If something’s askew, it is much more likely to be caught before final product leaves the building.

To learn about Tego’s sterilization-proof monitoring solutions for pharmaceutical manufacturing, please visit this page.

To schedule a demo and see if Tego can improve your aseptic manufacturing processes, contact us here.


Cleanroom Technology – Tego unveils touchless EM tracking for cGMP

“Tego’s Asset Intelligence Approach survives gamma sterilization, reduces risk of contamination and streamlines compliance processes for cGMP pharmaceutical facilities.”

Cleanroom Technology magazine spotlights Tego’s ability to enable digital data on critical gamma and eBeam-sterilized components used during aseptic (sterile) manufacturing, to solve for visibility and traceability mandates in FDA-regulated cGMP manufacturing environments.

Tego continues to redefine the use case for RFID data.

From the article:
Tego, a leading provider of smart asset solutions based in Waltham, MA, US, has produced an automated, touchless, digital solution for environmental monitoring within FDA-regulated pharmaceutical manufacturing facilities.

Tego’s Asset Intelligence Platform makes businesses smarter by embedding digital information in assets and components for the life sciences, healthcare, aerospace and manufacturing industries. Insights about assets’ lifecycle history, regulatory compliance and integrity can help to drive operational excellence and new revenue models.

Built on this platform, the latest solution applies advances in Industrial Internet of Things (IIoT) technology to precisely track and verify contaminant exposure on product, material or equipment used during production of aseptic pharmaceuticals.

The solution ensures that data is stored directly on environmental monitoring components; processes become automated and touchless so that manufacturers greatly reduce the possibility of contamination and limit the potential for costly wasted batches.

“Tego’s approach to progressive data on assets is gaining attention from pharmaceutical manufacturers because it helps minimize the potential for contamination and batch loss, and provides more complete traceability and visibility data as required by the FDA,” said Timothy Butler, founder and CEO of Tego.

Pharmaceutical manufacturers who perform aseptic processing are required to deliver meaningful information about the quality of the manufacturing environment during production. They must demonstrate to regulators that proper controls are in place, quickly discover problems or put themselves at risk of significant financial loss (one lost batch can cost $500,000 or more), and always have the right data at hand to support root cause analysis procedures.

All types of environmental monitoring – for airborne particulates, active viable air, passive viable air, surfaces, water, and personnel – benefit from this aseptic-proof, digital solution.

Staff are able to receive digital validation about the status of monitoring componentry and instantly update a component’s documentation as it changes across multiple prescribed points during CGMP manufacturing.

The digital environmental monitoring solution was born out of Tego’s work in the aerospace industry, where putting data on critical airplane parts and components has dramatically improved decision-making in the field, supported far more accurate reporting, extended products’ lifecycles, and produced significant cost savings.

Read the full article here.

To learn about Tego’s RFID chip and platform solutions for pharmaceutical manufacturing, visit this page.

To schedule a demo and see if Tego can improve your aseptic operation, contact us here.


RFID Journal – Touchless Environmental Monitoring for Pharmaceuticals

“The tags are designed for rugged environments and sustain temperatures that can vary widely from sub-freezing to gamma and electronic beam sterilization.”

Tego’s VP of Marketing LaVerne Cerfolio sat down with Claire Swedberg at this year’s RFID Journal Live to discuss our new, sterilization-proof solution for touchless environmental monitoring in pharmaceutical manufacturing facilities.

Tego continues to redefine RFID for high-value use cases.

RFID platform solution provider Tego, Inc. has released an RFID-based solution for tracking environmental-monitoring components to manage the presence of contaminants in places where vaccines or medications are being made. The Touchless Environmental Monitoring Solution is aimed at providing a history of each component and its chain of custody to better manage use and location, as well as what items or products were located around it in the event of a contamination. Items being tracked include agar exposure plates, cleanroom airflow monitoring filters, finished drug components, and raw materials and components used to monitor the environment.

Tego’s environmental-monitoring solution includes a passive ultrahigh-frequency UHF RFID tag that stores data written directly to it, as well as fixed or handheld readers from a variety of vendors, and Tego’s Asset Intelligence Platform (AIP) software to manage the collected read data. By using the solution with high-memory Tego tags, multiple entities can have access to the data written on the tag itself, even if they lack access to the software, explains LaVerne Cerfolio, Tego’s marketing VP.

The technology was developed as a solution for pharmaceutical companies to track such assets as the hundreds or thousands of agar exposure plates that they use to prevent contamination while making medications and vaccines. The U.S. Food and Drug Administration (FDA) mandates that companies follow Current Good Manufacturing Practices (CGMP) by certifying that every vaccine, drug or biologic product is produced in a safe and controlled environment. The plates are used to identify if any mold or other contamination takes place, thereby identifying a problem before it can reach a finished product or a patient.

RFID enables the tracking of those plates. However, because they are often moved from one workstation, lab or manufacturing facility to another, the plates can be the responsibility of multiple parties, who may or may not have access to a single software platform.

For this reason, Cerfolio explains, Tego provides tags with high-memory chips—24 kilobytes of memory—that store a unique device identifier (UDI), GS1 manufacturing information about the product itself, and any data written by those inspecting or handling the test sample.

Tego’s environmental-monitoring solution tag can be securely read and written to for use downstream, Cerfolio says, “by authorized personnel when critical supply chain events occur, or if changes in the products’ status are necessary.” Such changes may be required in such scenarios as a soft recall.

The tags are designed for rugged environments and to sustain temperatures that can vary widely from sub-freezing to gamma and electronic beam sterilization. Tego’s solution consists of the cloud-based Asset Intelligence platform with its Hub software dashboard, as well as the Tego Narrator App, which users can download on their reading device. “The software doesn’t favor any one device,” Cerfolio notes. “Rather, its power is that it enables the exchange of lots of information at the edge, between the operator and the asset, that has been made intelligent with Tego’s solution.”

In the case of agar exposure plates, tags are affixed to the plate’s exterior, and production data can be written to the tag and stored with its unique ID number, both on the tag itself and in the software. From that point forward, other information can also be added or stored, such as the identity of the culture in the plate, the due date or expiration date, the name of the manufacturing center or the identity of the test station within that facility, as well as the operator’s ID.

“Tego’s AIP is limitless,” Cerfolio says, “as far as the type of data that can be written and stored. Data could be structured or unstructured, an Excel file or an image.”

According to Cerfolio, companies will use the solution to automate the collection of data, thus ensuring that the agar plate does not need to be touched to access its ID or data, and to capture a history about the item itself and the people who have interacted with it. “In this way,” she states, “they can prove, batch by batch, compliance with FDA contaminant regulations.”

The solution follows Tego’s digital environmental-monitoring solution for the aerospace industry, in which critical airplane parts and components must be tracked and require high-memory tags, as well as software to store and interpret data

Read the full article: http://www.rfidjournal.com/articles/view?16136

To learn about Tego’s RFID chip and platform solutions for pharmaceutical manufacturing, visit this page.

And if you want to see Tego in action, contact us here.


Digitized Solution for Environmental Monitoring of FDA regulated cGMP Facilities

The FDA requires manufacturers operating under Current Good Manufacturing Practices (CGMP) to certify that every batch of drug, vaccine, or biologic be produced in a high quality controlled environment.

Digital Environmental Monitoring (EM) removes human factors and provides significant process improvement opportunities. These digital, data-driven solutions must survive sterilization. However, digital EM with sterilization-proof technology allows CGMP manufacturers to write data directly onto a) products and materials that must be tracked and verified before, during, and post-production and b) products and materials that monitor sterility. More importantly, digitized environmental monitorying makes data available via touchless, sightless procedures.

The digital traceability and visibility provides a full GMP compliance solution as well as an early warning system.

Tego’s environmental monitoring solution provides increased assurance of sterility for aseptically produced pharma and medical products.

Learn more about the solution here.


Flarrio: How IIoT Can Combat The Rising Tide of Counterfeit Drugs

Tego CEO Timothy Butler wrote a piece for Flarrio Magazine in January on the rising tide of counterfeit drugs and how the pharmaceutical industry can take cues from aerospace on how to react to this challenge.

Read the article here


Why RFID, barcoding fall short in the rush to life sciences serialization

0613_hto_csbarcode

As the pharmaceutical industry gears up for the next round of Drug Supply Chain Security Act (DSCSA) and 503B compliance measures, the challenge presents a favorable opportunity to turn away from thinking of compliance as a burden, and instead consider the compounded business benefits to be gained from a well-honed serialization strategy. Even in the absence of feeling forced to check the compliance box, there are a number of high-leverage financial and risk management implications that come from thinking beyond merely track and trace. Financial loss, patient safety and shareholder value all stand to win — or lose — on the shoulders of supply chain asset intelligence.

Over the years, the industry has employed several game plans designed to embed products in the supply chain with intelligence, to varying degrees of success. Primary among them: barcoding and, more recently, RFID.

Barcodes – Simple elegance, but simply not enough

Barcodes are the traditional, cost-efficient, easy-to-integrate solution for product tagging and tracking in the supply chain. But they do come with a number of limitations:

  • They must be individually read, which can be a drag on workforce productivity.
  • They cannot log critical data, such as chain-of-custody records or thermal monitoring for sensitive medicines.
  • They require a line-of-sight reader, meaning they cannot be read at the product level through materials like boxes and textiles. For serialization and future aggregation requirements, this is a crucial shortcoming.

But perhaps the largest issue with packaging-level barcode security is that it has proven to be vulnerable to counterfeiting. As a rule of thumb, consider that a credible forgery often surfaces within six months of deployment for most packaging-level security technologies. Criminals have access to digital printing, packaging duplication equipment, and are well-versed in every phase of the manufacturing and delivery process through recent globalization efforts in the pharmaceutical industry. On that score, progress begets challenge. Any criminal with a cheap but high-quality printer can imitate packaging designs, including bar codes.

Simple RFID tags — close, but not quite there

On the anti-counterfeiting front, RFID tags do allow a manufacturer to write digital content onto a product itself, which can then be verified at delivery to ensure a patient receives the proper product. However, once written, this identification data cannot be modified to reflect changing transport conditions or chain-of-custody updates.]

Moreover, RFID signal frequencies across the world are non-standardized. This issue in fact, highlights one of the biggest challenges in how to approach compliance: There is currently a wide range of technologies used to exchange product transaction data, with no clear standard. It is expected that the GS1’s EPCIS standard will play a role in the exchange of non-serialized and serialized data between now and 2023, but for now, it requires an interpretation by the actors involved. Better to be safe than sorry, and stick to solutions that interoperate within GS1.

A third, and more dramatic issue is survivability. Many RFID solutions on the market today cannot survive sterilization or other extreme processing conditions that may come into play during life sciences manufacturing and transport operations.

Smart Assets take healthcare to, and beyond, DSCSA and 503B

Tego’s approach has been to allow individual products – from airline seating to the myriad valves and meters holding together the World’s energy infrastructure – to maintain and share their own unique “storylines” from manufacture to distribution, to maintenance. Those stories range from e-pedigree to critical usage details – events and operations endured a certain time and date, or across a given time period – that will validate compliance with processes, guidelines, and safety best practices. In fact, Tego wrote the part identification and data capture standard for the Airline industry.

Tego has taken RFID, well, beyond RFID with a passive, connected technology that allows manufacturers to transform any asset into what is essentially a mini-computer that can be read and written upon as if it was a laptop or mobile device. Tego’s solution is rugged enough to survive gamma and e-beam sterilization, not to mention blistering heat, unlivable cold and deep-water environments. More importantly, it connects only when asked, to solve for growing security concerns around “always on” IoT devices. Making an asset smart does not require a complicated IT infrastructure, an IP addressing scheme or even a power source.

What does the Smart Asset approach mean for healthcare? When you digitize the supply chain there are benefits that go well beyond track and trace. You enable significant improvements in inventory management and manufacturing lead times. You gain better forecasting capabilities with real-time, understanding of what’s happening, everywhere across the multi-layered supply chain. You dramatically improve recall processes by gaining visibility into granular-level product details for an early, almost surgical removal of only unfit products (and no more). And you become a value-adding entity up and down the entire value chain because you have the right data to share with partners at the right time, with no lag. In essence, you become a conduit for tighter industry-wide controls, auditing and revenue protection.

The coming serialization mandates give us all a chance to be smarter. Grab hold of the opportunity to do more to strengthen your value chain, perfect the electronic chain of custody process, improve patient safety, and stop counterfeiters in their tracks.


Frost & Sullivan Presents Tego with 2016 United States Asset Intelligence for Healthcare New Product Innovation Award

Tego Brings Compliance and Lifecycle Intelligence to Pharmaceutical Manufacturing, Medical Devices and Lab Processes

MOUNTAIN VIEW, Calif., Sept. 27, 2016 /PRNewswire/ — Based on its recent analysis of asset intelligence solutions for the healthcare market, Frost & Sullivan bestowed Tego, Inc. the 2016 North America Frost & Sullivan Award for New Product Innovation. Tego’s Asset Intelligence Platform (AIP) is recognized as one of the most innovative solutions for Internet of Things (IoT) applications in the healthcare industry pertaining to smart asset management for hospitals, drug and device manufacturers, distributors, and sterilization service companies. The solution makes every asset smart by embedding local intelligence on products for enhanced quality management, visibility and data accuracy, and much safer use.

Frost & Sullivan Presents Tego with 2016 United States Asset Intelligence for Healthcare New Product Innovation Award


Smart Asset Solution in Complex Manufacturing Setting

Life science companies and medical device manufacturers can maximize operational efficiencies when critical product data and information is readily available throughout their value chain — from manufacture to distribution to end use. Tego’s AIP solution benefits pharma, medical device manufacturers and healthcare service providers by providing unprecedented manufacturing visibility and availability of product and regulatory compliance data.

Tego Platform captures product data rugged enough to survive sterilization and other manufacturing processes, while enabling aseptic manufacturing. This breakthrough technology is bringing the benefits of the Industrial Internet of Things (IIoT) to new industries such as life sciences and healthcare. As demonstrated in the solution brochure, the benefits come in many forms, including dramatic increases in process efficiencies and reduced production costs.


Frost & Sullivan Asset Intelligence for Healthcare: New Product Innovation Award

Tego recognized as one of the pioneers in smart asset management solutions, with its proven asset intelligence platform (AIP) solution targeted towards the healthcare industry. Makes every asset smart by bringing intelligence to things that have been unreachable with conventional IoT solutions.

 

 


The Smart Asset Revolution in Life Sciences

Learn how Tego’s Smart asset solutions are helping manufacturers, serialization service companies, distribution centers and hospitals bring quality, time and process improvements to their operations


The Internet of Things UDI and Medical Device Compliance

For medical device companies, information will become the foundation for their manufacturing, and it will be augmented by more data about the product’s distribution, condition, and directions for use, re-use, and upkeep. In other words, devices will ship with a pedigree and become embedded with a digital record of their entire life history. That local information will be the benefit made available for all stakeholders.

Read the article


Technology Advances Fuel SPD Progress, Quality Assurance Goals

The nation’s largest tissue bank, the Musculoskeletal Transplant Foundation, is currently using Tego RFID tags to track their allograft tissues (bone, skin and soft tissues). This customer offers high quality tissue by having some of the most stringent standards in the industry. The added benefit of Tego RFID solutions helps them to maintain their high standards by providing accurate, real-time information about the status and location of tagged assets, tracking them from the point of collection throughout their facility.

Read the full article


Super-Rugged RF Solution Survives All Forms of Sterilization

The ultra high frequency (UHF) radio frequency TegoChip can easily stand up to gamma, eBeam, autoclave, and ethylene oxide sterilization without performance degradation.

Read the full article


Simplify Complex Biologics Supply Chain with RFID Smart Asset Management

RFID technology has been adopted for diverse applications in a wide range of industries. However, for many years, the life sciences and healthcare fields missed out on the full benefits that RFID delivers because they did not have a solution that could survive their specific rugged supply chain needs. Traditional RFID chips and tags are not capable of surviving sterilization by gamma and e-beam radiation.

Fortunately, Tego has the first UHF RFID technology proven to withstand gamma, ebeam, ethylene oxide, and autoclave sterilization methods, as well as cold storage to -80C. This enables an entire industry to incorporate RFID into medical device manufacturing and labelling, biologic processing and healthcare supply chain processes.

In one particular application, Tego is working with a large life sciences provider that uses gamma and e-beam sterilization in its manufacturing process. Their products are processed and stored in bottles, which have been fitted with Tego’s passive UHF tags. The provider maintains a running inventory of more than 20 million bottles, which are kept in a deep freeze for up to 60 days before final processing and delivery.

A key challenge is the need for cradle-to-grave traceability, in the event that manufacturing problems should trigger recalls. Tracking each and every bottle with a high level of efficiency – and without disrupting their entire business operation – is a formidable task that was previously addressed with an elaborate barcode system. However, the barcode reading process was labor-intensive and susceptible to reading errors due to the extreme cold.

Additionally, the company maintains a supply chain that’s spread across several hundred locations worldwide, making it cost prohibitive to create a company-wide, global database of inventory. The Tego solution enables radiation-resistant RFID tags to be applied to each pharmaceutical bottle and to store unique identifying numbers, as well as separate information about the bottle’s contents and whereabouts throughout the supply chain.

To allow end-to-end visibility of the data throughout the healthcare supply chain, Tego tailored their TegoView software for this particular application to enhance overall productivity and efficiency. The company is seeing significant benefits with the Tego RFID system fully deployed.

When the company used barcode labels to track products, shipping pallets often had to be broken down and cases opened so that workers could manually scan bottles one at a time. Now with the Tego solution, all the bottles inside a case can be read without opening the lid. As a result, a shipment that used to take eight hours to process can now be received in roughly 30 minutes.

Furthermore, the Tego solution eliminated the need to build a costly corporate network for sharing data collected at each location throughout the global supply chain. The high-memory TegoTag allows collected information to be stored directly with the asset, allowing each location to maintain a local database for a smaller, more secure and more cost-efficient solution. When bottles are inspected, either by quality assurance personnel or by government agencies, they can simply read the RFID tag to get the entire history of the bottle and its contents.

To learn more about how radiation-resistant RFID technology is benefitting the life sciences and healthcare field, and to read more details about this application, click here.

How can we help you solve your unique challenges?


Verified by MonsterInsights